Skip to main content
Clinical Trials/ACTRN12618001810202
ACTRN12618001810202
Recruiting
未知

Development of imaging biomarkers for accurate and informative assessment of treatment outcome following prostate radiotherapy. The BiRT Sequential Imaging” project (SI-BiRT).

niversity of Sydney0 sites30 target enrollmentNovember 6, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Sydney
Enrollment
30
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Biopsy proven localised prostate cancer.
  • Great than or equal to 18 years of age.
  • Willing and able to comply with all study requirements.
  • Signed, written and informed consent.
  • Completed MRI safety screening as per local policy.
  • Up to 4 months ADT prior to radiotherapy.
  • No more than 20 participants who receive ADT.

Exclusion Criteria

  • Mentally impaired participants or participants for who obtaining informed consent would be difficult.
  • Unable to undergo an MRI examination or has contraindications to MRI.
  • Inadequate renal function for contrast administration (eGFR \<60 ml/min) at baseline imaging.
  • Participants who have been clinically diagnosed with severe claustrophobia.
  • Prior pelvic radiotherapy.
  • Any prosthetic implants such as metallic hip prostheses that may cause artefacts in the imaging studies.

Outcomes

Primary Outcomes

Not specified

Similar Trials